553 related articles for article (PubMed ID: 8313316)
1. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.
Leung NW; Tam JS; Lau GT; Leung TW; Lau WY; Li AK
Cancer; 1994 Feb; 73(4):1143-8. PubMed ID: 8313316
[TBL] [Abstract][Full Text] [Related]
2. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
[TBL] [Abstract][Full Text] [Related]
4. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
Ahn JM; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
PLoS One; 2015; 10(12):e0144777. PubMed ID: 26696302
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
[TBL] [Abstract][Full Text] [Related]
7. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
8. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
9. State of hepatitis B virus DNA in peripheral blood mononuclear cells from persistently infected individuals: correlation with e antigen and viral DNA in the serum as well as with the activity of liver disease.
Sugai Y; Okamoto H
Tohoku J Exp Med; 1989 May; 158(1):73-84. PubMed ID: 2781542
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of HBV, HCV and HDV serum markers in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)].
Zeng WZ; Chu RJ; Jiang MD
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):167-9. PubMed ID: 8222980
[TBL] [Abstract][Full Text] [Related]
11. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus DNA in leukocytes of patients with hepatitis B virus-associated liver diseases.
Shen HD; Choo KB; Lee SD; Tsai YT; Han SH
J Med Virol; 1986 Mar; 18(3):201-11. PubMed ID: 3009696
[TBL] [Abstract][Full Text] [Related]
13. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma.
Robinson WS; Klote L; Aoki N
J Med Virol; 1990 May; 31(1):18-32. PubMed ID: 2165515
[TBL] [Abstract][Full Text] [Related]
14. Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.
Feinman SV; Berris B; Fay O; Sooknanan R; Tanno HE; Tung WW; Lieberman HM
Clin Invest Med; 1988 Aug; 11(4):286-91. PubMed ID: 3168350
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
Mendy ME; Welzel T; Lesi OA; Hainaut P; Hall AJ; Kuniholm MH; McConkey S; Goedert JJ; Kaye S; Rowland-Jones S; Whittle H; Kirk GD
J Viral Hepat; 2010 Feb; 17(2):115-22. PubMed ID: 19874478
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.
Pasquinelli C; Lauré F; Chatenoud L; Beaurin G; Gazengel C; Bismuth H; Degos F; Tiollais P; Bach JF; Bréchot C
J Hepatol; 1986; 3(1):95-103. PubMed ID: 3018075
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
18. [Identification of latent HBV infection in primary hepatic carcinoma and liver cirrhosis with polymerase chain reaction].
Yang JM; Liu WW
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):152-4. PubMed ID: 8222976
[TBL] [Abstract][Full Text] [Related]
19. Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
Nien HC; Sheu JC; Kao JH; Chou HC; Su CW; Chen CH
J Med Virol; 2011 Aug; 83(8):1326-31. PubMed ID: 21678436
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
